p53 in biopsies of oral squamous cell carcinoma. A comparative study with a malignancy grading system

European Journal of Cancer Part B: Oral Oncology

Volumn 33, Issue 1, 1997, Pages 5-9

  De Araujo V C ^a   Loyola, A M ^b   Santos Pinto Jr , D D ^b   Borra, R C ^a   De Araujo N S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Malignancy grading system; Oral cancer; p53 Protein

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030898457     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-1955(96)00055-3     Document Type: Article

References (21)

1. 1. Anneroth, G., Batsakis, J. and Luna, M., Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scandinavian Journal of Dental Research, 1987, 95, 229-249.
2. 2. Araújo, V. C., Santos Pinto, D. Jr, Souza de, S. O. M., Nunes, F. D. and Araújo, N. S., Vimentin in oral squamous cell carcinoma. European Archives of Otarhinolaryngology, 1993, 250, 105-109.
3. 3. Bryne, M., Prognostic value of various molecular and cellular features in oral squamous cell carcinomas: a review. Journal of Oral Pathology and Medicine, 1991, 20, 413-420.
4. 4. Fielding, L. P., Fenoglio-Preiser, C. M. and Fredman, L. S., The future of prognostic factors in outcome prediction for patients with cancer. Cancer, 1992, 70, 367-2377.
5. 5. Kawai, A., Nogushi, M., Beppu, Y., et al., Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor. Cancer, 1994, 73, 2499-2505.
6. 6. Gerdes, J., Becker, M. H. G., Key, G. and Cattoret, G., Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. Journal of Pathology, 1992, 168, 85-87.
7. 7. Lane, D. P., p53, guardian of the genome. Nature, 1992, 358, 15-16.
8. 8. Symounds, H., Krall, L., Remington, L., et al., p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 1994, 78, 703-711.
9. 9. Harris, C. C., At the crossroads of molecular carcinogenesis and risk assessment. Science, 1993, 262, 1980-1981.
10. 10. Levine, A. J., Momand, J. and Finlay, C. A., The p53 suppressor gene. Nature, 1991, 351, 453-456.
11. 11. Esrig, D., Spruck, C. H. III, Nichols, P. W., et al., p53 protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. American Journal of Pathology, 1993, 143, 1389-1397.
12. 12. Field, J. K., Malliri, A., Butt, S. A., et al., Over-expression in end stage squamous cell carcinomas of the head and neck: correlates with a very poor clinical outcome. International Journal of Oncology, 1993, 3, 431-435.
13. 13. Lee, Y.-S. and Teh, M., p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin. Cancer, 1994, 73, 2317-2323.
14. 14. Warnakulasuryia, K. A. A. S. and Johnson, N. W., Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. Journal of Oral Pathology and Medicine, 1992, 21, 404-408.
15. 15. Warnakulasuryia, K. A. A. S. and Johnson, N. W., Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. Journal of Oral Pathology and Medicine, 1994, 23, 246-250.
16. 16. Shi, S. R., Key, M. E. and Kalra, K. L., Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. Journal of Histochemistry and Cytochemistry, 1991, 39, 741-748.
17. 17. Matos, D., Saad, S. S., Franceschi, O. Jr, Barreto, E. P. Novelli, M. D., Colonic anastomosis with the biofragmentable ring and manual suture. Coloproctology, 1994, 16, 169-173.
18. 18. McDonald, P. S., Pavelic, Z. P., Stambrook, P. J., et al., Association of p53 expression with survival in early state T1 oral cavity cancer (OCC). Annals of the American Academy of Oral Pathology, 1994, 25.
19. 19. Ogden, G. R., Roy, A. K., Lunny, D. P. and Lane, D. P., Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. Journal of Pathology, 1992, 166, 389-394.
20. 20. Watling, D. L., Gown, A. M. and Coltrera, M. D., Overexpression of p53 in head and neck cancer. Head and Neck, 1992, 14, 437-444.
21. 21. Langdon, J. D. and Partridge, M., Expression of the tumour suppressor gene p53 in oral cancer. British Journal of Oral Maxillofacial Surgery, 1992, 30, 214-220.